Skip to content

Clinical trials

Phase 3 Dyslipidemias trials in Denmark

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dyslipidemias Phase: Phase 3 Country / region: Denmark Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20055
20064
20092
20121
20132
20141
20172
20212
20231
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Active, not recruiting2
Terminated2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Kowa Research Europe8
Amgen3
Novartis Pharmaceuticals2
Amarin Pharma Inc.1
Arrowhead Pharmaceuticals1
AstraZeneca1
Hoffmann-La Roche1
Kowa Research Institute, Inc.1
NewAmsterdam Pharma1
Sanofi1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dyslipidemias22
Hypercholesterolemia11
Diabetes Mellitus, Type 23
Hyperlipidemias3
Atherosclerosis2
Cardiovascular Diseases2
Coronary Disease2
Hyperlipoproteinemia Type II2
Hypertriglyceridemia2
Congenital, Hereditary, and Neonatal Diseases and Abnormalities1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.